Results 171 to 180 of about 39,557 (290)
A thin Maxwellian‐view VR near‐eye display based on a holographic optical element (HOE) is presented. Integrating the HOE with the display panel eliminates the structural gap, achieving an 8‐mm internal spacing. Accommodation‐independent image sharpness is experimentally verified over a 0‐ to 3.3‐D range, mitigating the vergence–accommodation conflict.
Minseong Kim +2 more
wiley +1 more source
Wearable devices detect physiological changes that precede and are associated with symptomatic and inflammatory rheumatoid arthritis flares. [PDF]
Sharma P +8 more
europepmc +1 more source
In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert +13 more
wiley +1 more source
Coronal dimmings and what they tell us about solar and stellar coronal mass ejections. [PDF]
Veronig AM +12 more
europepmc +1 more source
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou +2 more
wiley +1 more source
Hidradenitis suppurativa (HS) is often diagnosed late, complicating management. In this nationwide Danish study including 10,196 patients with dermatologist‐verified HS, we examined treatment patterns before and after referral to specialised hospital care.
Nana A. L. Rosenø +8 more
wiley +1 more source
ABSTRACT Background Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease characterised by painful nodules, abscesses, and draining and non‐draining tunnels. Currently, there are two biologics approved in Canada for the treatment of moderate‐to‐severe HS, adalimumab (anti‐TNF) and secukinumab (anti‐IL‐17A).
Irina Turchin +4 more
wiley +1 more source
Real-world Evidence of Self-reported Treatments, Signs, and Symptom Burden in Chronic Hand Eczema: Findings from the Multinational CHECK Study. [PDF]
Molin S +9 more
europepmc +1 more source
New Biologic and Small Molecule Therapies for Hidradenitis Suppurativa
ABSTRACT Hidradenitis suppurativa (HS) is an inflammatory skin disease that has historically been underdiagnosed and, until recently, under‐researched. Furthermore, the pathophysiology of HS is complex, and not fully understood. Just three biologic medications—adalimumab (anti‐TNF‐α), secukinumab (anti‐IL17A) and bimekizumab (anti‐IL17A/F) are licensed
Emily Pender +2 more
wiley +1 more source
Spectroscopic Analysis and RHD Modeling of the First Ca II H and H ϵ Flare Spectra from DKIST/ViSP. [PDF]
Tamburri C +9 more
europepmc +1 more source

